Holen Sie sich die Stockscreener-App
9.98
0.10%
-0.010
Vorhandelsmarkt:
10.00
0.02
+0.20%
Schlusskurs vom Vortag:
$9.99
Offen:
$10
24-Stunden-Volumen:
4,259
Relative Volume:
0.05
Marktkapitalisierung:
$234.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.98
$10.00
1-Wochen-Bereich:
$9.96
$10.00
52-Wochen-Spanne:
$9.94
$10.00
Apogee Acquisition Corp Stock (AACP) Company Profile
Firmenname
Apogee Acquisition Corp
Sektor
Branche
Telefon
771.210.4643
Adresse
2106 HOUSE AVE SUITE 375, CHEYENNE
Compare AACP vs LION, XXI, UMAC, DMII, BCSS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AACP
Apogee Acquisition Corp
|
9.98 | 234.47M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
15.21 | 4.50B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.74 | 1.91B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
22.57 | 1.19B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 643.37M | 0 | 8.58M | -1.11M | 0.134 |
BCSS
Bain Capital Gss Investment Corp
|
10.27 | 596.26M | 0 | 8.29M | -686.50K | 0.142 |
Apogee Acquisition Corp Aktie (AACP) Neueste Nachrichten
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition - Insider Monkey
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Investing News Network
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - 102.7 WBOW
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE) - Seeking Alpha
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
AbbVie Acquires Apogee Therapeutics in 10.9 Billion Dollar Deal - HarianBasis.co
Apogee Enterprises Acquires Kalwall Companies for 115 Million Dollars - HarianBasis.co
AbbVie acquires Apogee Therapeutics for $10.9 billion - qz.com
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Insider Monkey
AbbVie Acquires Apogee Therapeutics for 10.9 Billion Dollars - HarianBasis.co
AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline - streamlinefeed.co.ke
AbbVie Bets Big on Respiratory Pipeline With Apogee Acquisition -- Company Talk - Moomoo
AbbVie to acquire Apogee Therapeutics (NASDAQ: APGE) in $10.9B cash deal - Stock Titan
AbbVie (ABBV) Stock Dips as $10.9B Apogee Therapeutics Acquisition Nears Completion - MEXC
AbbVie pays $10.9B for Apogee to expand immunology pipeline - Stock Titan
AbbVie (ABBV) Pursues $10.9B Apogee Acquisition: JPMorgan Calls It Strategic Win - parameter.io
‘A Solid Fit’: JPMorgan Backs AbbVie’s Potential $11B Apogee Acquisition - TipRanks
AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says - Investing.com
AbbVie Closes In on 10.9 Billion Dollar Apogee Acquisition - HarianBasis.co
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Apogee Acquisition Corp Statistics – BOATS:AACPU - TradingView
Top ARC Group Acquisition I (ARCL) Competitors 2026 - MarketBeat
AACP Technical Analysis & Stock Price Forecast - Intellectia AI
AACP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AACP Forecast — Price Prediction for 2026. Should I Buy AACP? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
AACP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Income Statement - Intellectia AI
AACP News & Events - Intellectia AI
Apogee Therapeutics (NASDAQ: APGE) investors back board, pay and auditor - Stock Titan
Top Apogee Acquisition (AACP) Competitors 2026 - MarketBeat
AACP Should I Buy - Intellectia AI
Apogee Acquisition Corp Revenue Breakdown – NASDAQ:AACPR - TradingView
Apogee Acquisition Corp Income Statement – BOATS:AACPR - TradingView
What is the current Price Target and Forecast for Apogee Acquisition Corp. (AACP) - Zacks Investment Research
Apogee Acquisition Corp Rights (AACPR) AI-Powered Stock Analysis - Meyka
Apogee Acquisition Corp Warrant (AACPW) AI-Powered Stock Analysis - Meyka
Why Is Apogee Acquisition Corp Rights (AACPR) Stock Down Today? - Meyka
Apogee Acquisition Corp Class A Ordinary Shares (AACP) Stock Overall Grade - Meyka
Return on equity % of Apogee Acquisition Corp – BOATS:AACPW - TradingView
AACPW | Apogee Acquisition Corp Warrant Institutional Ownership - Quiver Quantitative
Apogee Acquisition Corp. (AACP) Cash From Financing (TTM) - Zacks Investment Research
Apogee Acquisition (AACP) Stock Price, News & Analysis - MarketBeat
Apogee Acquisition Corp Statistics – BOATS:AACPW - TradingView
Top ACP Holdings Acquisition (ACGC) Competitors 2026 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Apogee Acquisition (AACP) 10K Form and Latest SEC Filings 2026 - MarketBeat
Apogee Acquisition Corp. (AACP) - Zacks Investment Research
Non-operating income (total) of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Latest Apogee Acquisition Corp Class A Ordinary Shares Stock News & AACP Headlines - CoinCodex
Finanzdaten der Apogee Acquisition Corp-Aktie (AACP)
Es liegen keine Finanzdaten für Apogee Acquisition Corp (AACP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):